Problems caused unwanted immunogenicity of therapeutic proteins
- Authors: Avdeeva Z.I1, Soldatov AA1, Bondarev VP1, Medunitsyn NV1
-
Affiliations:
- Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation
- Issue: Vol 16, No 1S (2019)
- Pages: 11-12
- Section: Articles
- URL: https://ogarev-online.ru/raj/article/view/121397
- ID: 121397
Cite item
Abstract
.
Full Text
##article.viewOnOriginalSite##About the authors
Zh I Avdeeva
Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation
Author for correspondence.
Email: avd-cytok@yandex.ru
Россия, г. Москва
A A Soldatov
Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation
Email: avd-cytok@yandex.ru
Россия, г. Москва
V P Bondarev
Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation
Email: avd-cytok@yandex.ru
Россия, г. Москва
N V Medunitsyn
Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation
Email: avd-cytok@yandex.ru
Россия, г. Москва
References
- Hermeling S., Crommelin D. Structure-immunogenicity relationships of therapeutic proteins. Pharm. Res. 2004; 21(6): 897-903
Supplementary files
